Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-PEGylation)

Details for Australian Patent Application No. 2009307729 (hide)

Owner Nektar Therapeutics Baxter International Inc. Baxter Healthcare S.A.

Inventors Varadi, Katalin; Schrenk, Gerald; Rottensteiner, Hanspeter; Turecek, Peter; Weber, Alfred; Anderle, Heinz; Culbertson, Sean M.; Fang, Zhihao; Zappe, Harold; Zhang, Ping; Bossard, Mary J.

Agent Cullens

Pub. Number AU-A-2009307729

PCT Pub. Number WO2010/048184

Priority 61/107,257 21.10.08 US; 61/242,634 15.09.09 US

Filing date 20 October 2009

Wipo publication date 29 April 2010

International Classifications

G01N 33/542 (2006.01) Investigating or analysing materials by specific methods not covered by groups

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

G01N 33/86 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving blood coagulating time

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/048184 Priority application(s): WO2010/048184

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009307732-Roofing materials with metallic appearance

2009307728-Antibodies that bind to IL-18 and methods of purifying the same